 | • レポートコード：MRC23Q38461 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のセービン不活化ポリオワクチン（sIPV）市場について調査・分析し、世界のセービン不活化ポリオワクチン（sIPV）市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（バイアル、シリンジ）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Biokangtai、Sinovac、Imbcams、Intravacc、Beijing Biologicalなどが含まれています。世界のセービン不活化ポリオワクチン（sIPV）市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、セービン不活化ポリオワクチン（sIPV）市場規模を推定する際に考慮しました。本レポートは、セービン不活化ポリオワクチン（sIPV）の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、セービン不活化ポリオワクチン（sIPV）に関するビジネス上の意思決定に役立てることを目的としています。 ・セービン不活化ポリオワクチン（sIPV）市場の概要 - 製品の定義 - セービン不活化ポリオワクチン（sIPV）のタイプ別セグメント - 世界のセービン不活化ポリオワクチン（sIPV）市場規模：タイプ別分析（バイアル、シリンジ） - セービン不活化ポリオワクチン（sIPV）の用途別セグメント - 世界のセービン不活化ポリオワクチン（sIPV）市場規模：用途別分析（病院、クリニック、その他） - 世界のセービン不活化ポリオワクチン（sIPV）市場規模予測（2018年-2029年） - セービン不活化ポリオワクチン（sIPV）の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - セービン不活化ポリオワクチン（sIPV）市場の競争状況およびトレンド ・セービン不活化ポリオワクチン（sIPV）の地域別市場規模 - 北米のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - アメリカのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - ヨーロッパのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - アジア太平洋のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - 中国のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - 日本のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - 韓国のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - インドのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - オーストラリアのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - 中南米のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） - 中東・アフリカのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年） ・タイプ別セグメント：バイアル、シリンジ - 世界のセービン不活化ポリオワクチン（sIPV）のタイプ別販売量（2018年-2023年） - 世界のセービン不活化ポリオワクチン（sIPV）のタイプ別売上（2018年-2023年） - 世界のセービン不活化ポリオワクチン（sIPV）のタイプ別価格 ・用途別セグメント：病院、クリニック、その他 - 世界のセービン不活化ポリオワクチン（sIPV）の用途別販売量（2018年-2023年） - 世界のセービン不活化ポリオワクチン（sIPV）の用途別売上（2018年-2023年） - 世界のセービン不活化ポリオワクチン（sIPV）の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Biokangtai、Sinovac、Imbcams、Intravacc、Beijing Biological ・産業チェーンと販売チャネルの分析 - セービン不活化ポリオワクチン（sIPV）産業チェーン分析 - セービン不活化ポリオワクチン（sIPV）の主要原材料 - セービン不活化ポリオワクチン（sIPV）の販売チャネル - セービン不活化ポリオワクチン（sIPV）のディストリビューター - セービン不活化ポリオワクチン（sIPV）の主要顧客 ・セービン不活化ポリオワクチン（sIPV）市場ダイナミクス - セービン不活化ポリオワクチン（sIPV）の業界動向 - セービン不活化ポリオワクチン（sIPV）市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Sabin Inactivated Polio vaccine (sIPV) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Sabin Inactivated Polio vaccine (sIPV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Sabin Inactivated Polio vaccine (sIPV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Sabin Inactivated Polio vaccine (sIPV) include Biokangtai, Sinovac, Imbcams, Intravacc and Beijing Biological, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sabin Inactivated Polio vaccine (sIPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sabin Inactivated Polio vaccine (sIPV).
The Sabin Inactivated Polio vaccine (sIPV) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sabin Inactivated Polio vaccine (sIPV) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sabin Inactivated Polio vaccine (sIPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Biokangtai
Sinovac
Imbcams
Intravacc
Beijing Biological
Segment by Type
Vials
Syringes
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sabin Inactivated Polio vaccine (sIPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sabin Inactivated Polio vaccine (sIPV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Sabin Inactivated Polio vaccine (sIPV) Market Overview
1.1 Product Overview and Scope of Sabin Inactivated Polio vaccine (sIPV)
1.2 Sabin Inactivated Polio vaccine (sIPV) Segment by Type
1.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Type (2023-2029)
1.2.2 Vials
1.2.3 Syringes
1.3 Sabin Inactivated Polio vaccine (sIPV) Segment by Application
1.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Sabin Inactivated Polio vaccine (sIPV) Market Size Estimates and Forecasts
1.4.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue 2018-2029
1.4.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales 2018-2029
1.4.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sabin Inactivated Polio vaccine (sIPV) Market Competition by Manufacturers
2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Manufacturers (2018-2023)
2.4 Global Sabin Inactivated Polio vaccine (sIPV) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Product Type & Application
2.7 Sabin Inactivated Polio vaccine (sIPV) Market Competitive Situation and Trends
2.7.1 Sabin Inactivated Polio vaccine (sIPV) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sabin Inactivated Polio vaccine (sIPV) Players Market Share by Revenue
2.7.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sabin Inactivated Polio vaccine (sIPV) Retrospective Market Scenario by Region
3.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sabin Inactivated Polio vaccine (sIPV) Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2018-2029
3.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2018-2023
3.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2024-2029
3.3 Global Sabin Inactivated Polio vaccine (sIPV) Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2018-2029
3.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2018-2023
3.3.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2024-2029
3.4 North America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.4.1 North America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.4.3 North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.5.1 Europe Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.5.3 Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.6.1 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.6.3 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.7.1 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.7.3 Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2018-2029)
4.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2018-2023)
4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2024-2029)
4.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2018-2029)
4.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2018-2029)
4.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2018-2023)
4.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2024-2029)
4.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2018-2029)
4.3 Global Sabin Inactivated Polio vaccine (sIPV) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2018-2029)
5.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2018-2023)
5.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2024-2029)
5.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2018-2029)
5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2018-2029)
5.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2018-2023)
5.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2024-2029)
5.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2018-2029)
5.3 Global Sabin Inactivated Polio vaccine (sIPV) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biokangtai
6.1.1 Biokangtai Corporation Information
6.1.2 Biokangtai Description and Business Overview
6.1.3 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.1.5 Biokangtai Recent Developments/Updates
6.2 Sinovac
6.2.1 Sinovac Corporation Information
6.2.2 Sinovac Description and Business Overview
6.2.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.2.5 Sinovac Recent Developments/Updates
6.3 Imbcams
6.3.1 Imbcams Corporation Information
6.3.2 Imbcams Description and Business Overview
6.3.3 Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Imbcams Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.3.5 Imbcams Recent Developments/Updates
6.4 Intravacc
6.4.1 Intravacc Corporation Information
6.4.2 Intravacc Description and Business Overview
6.4.3 Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intravacc Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.4.5 Intravacc Recent Developments/Updates
6.5 Beijing Biological
6.5.1 Beijing Biological Corporation Information
6.5.2 Beijing Biological Description and Business Overview
6.5.3 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.5.5 Beijing Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sabin Inactivated Polio vaccine (sIPV) Industry Chain Analysis
7.2 Sabin Inactivated Polio vaccine (sIPV) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sabin Inactivated Polio vaccine (sIPV) Production Mode & Process
7.4 Sabin Inactivated Polio vaccine (sIPV) Sales and Marketing
7.4.1 Sabin Inactivated Polio vaccine (sIPV) Sales Channels
7.4.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
7.5 Sabin Inactivated Polio vaccine (sIPV) Customers
8 Sabin Inactivated Polio vaccine (sIPV) Market Dynamics
8.1 Sabin Inactivated Polio vaccine (sIPV) Industry Trends
8.2 Sabin Inactivated Polio vaccine (sIPV) Market Drivers
8.3 Sabin Inactivated Polio vaccine (sIPV) Market Challenges
8.4 Sabin Inactivated Polio vaccine (sIPV) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer